SCHEMBL9702719

SCHEMBL9702719

CCCCC(C(=O)O)C1NCCc2cc(OC)c(OC)cc21

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 0.47
▸ TSHR P16473 1/20 0.47
▸ KMT2A Q03164 4/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ BCHE P06276 1/20 0.43
▸ GRIN2D O15399 5/20 0.43
▸ GRIN3B O60391 5/20 0.43
▸ GRIN1 Q05586 5/20 0.43
▸ GRIN2A Q12879 5/20 0.43
▸ GRIN2B Q13224 5/20 0.43
▸ GRIN2C Q14957 5/20 0.43
▸ GRIN3A Q8TCU5 5/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MAPK1 P28482 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9703241 0.88 KMT2A (0.48) MAOATSHRKMT2AMEN1BCHE
SCHEMBL3763814 0.79 MAPKAPK2 (0.35) KMT2A
SCHEMBL10903430 0.78 MAOA (0.48) MAOATSHRKMT2AMEN1BCHE
SCHEMBL9703245 0.76 KCNN2 (0.50) MAOAGRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL9700855 0.76 KCNN2 (0.51) MAOAGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL10642003 0.74 MAOA (0.57) MAOATSHRKMT2AMEN1BCHE
SCHEMBL1819006 0.73 MAOA (0.64) MAOATSHRKMT2AMEN1BCHE
Bromide SCHEMBL10706879 0.73 MAOA (0.56) MAOATSHRKMT2AMEN1BCHE
Hydrochloric Acid SCHEMBL10636936 0.73 MAOA (0.58) MAOATSHRKMT2AMEN1BCHE
Bisobrin SCHEMBL564266 0.72 GRIN2D (0.55) MAOATSHRKMT2ABCHEGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992014465-A1 USE OF ANNULATED TETRAHYDROPYRIDINACETIC ACID DERIVATES FOR TREATING NEUROLOGICAL DISEASES BOEHRINGER INGELHEIM KG (DE) 1992-09-03 — — WO disclosed
EP-0358957-A1 Fused tetrahydropyridineacetic acid derivatives, process for their preparation, and use of such compounds for the cardioprotection BOEHRINGER INGELHEIM KG (DE) 1990-03-21 — — EP disclosed
Send feedback